Loading...
Loading...
Below are the top drugs generic stocks on the NYSE and the NASDAQ in terms of EPS estimates for the next quarter.
Watson Pharmaceuticals Inc
WPI is likely to earn $0.85 in the September quarter. WPI has a PEG ratio of 0.90.
Hi Tech Pharmacal Co Inc
HITK is expected to earn $0.52 in the September quarter. HITK’s quarterly earnings grew 312.40% y/y.
The earnings estimate for Par Pharmaceutical Companies Inc
PRX for the September quarter is $0.51. PRX’s quarterly earnings growth stands at 63.60%.
Mylan Inc
MYL is likely to earn $0.44 in the September quarter. Oppenheimer initiated coverage of MYL with an “outperform” rating.
You Can't Afford Miss Out On These Money Making Trading
Ideas© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in